NovaBay Pharmaceuticals (NBY) Inventory (2016 - 2025)
Historic Inventory for NovaBay Pharmaceuticals (NBY) over the last 14 years, with Q2 2025 value amounting to $467000.0.
- NovaBay Pharmaceuticals' Inventory fell 3328.57% to $467000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $467000.0, marking a year-over-year decrease of 3328.57%. This contributed to the annual value of $501000.0 for FY2023, which is 8542.33% down from last year.
- Per NovaBay Pharmaceuticals' latest filing, its Inventory stood at $467000.0 for Q2 2025, which was down 3328.57% from $473000.0 recorded in Q3 2024.
- In the past 5 years, NovaBay Pharmaceuticals' Inventory registered a high of $4.1 million during Q3 2022, and its lowest value of $467000.0 during Q2 2025.
- Moreover, its 5-year median value for Inventory was $2.1 million (2021), whereas its average is $2.1 million.
- As far as peak fluctuations go, NovaBay Pharmaceuticals' Inventory skyrocketed by 45733.14% in 2022, and later crashed by 8645.86% in 2024.
- Over the past 5 years, NovaBay Pharmaceuticals' Inventory (Quarter) stood at $3.2 million in 2021, then increased by 6.74% to $3.4 million in 2022, then tumbled by 85.42% to $501000.0 in 2023, then decreased by 5.59% to $473000.0 in 2024, then fell by 1.27% to $467000.0 in 2025.
- Its Inventory was $467000.0 in Q2 2025, compared to $473000.0 in Q3 2024 and $700000.0 in Q2 2024.